Resmed Inc (NYSE: RMD) is -6.71% lower on its value in year-to-date trading and has touched a low of $172.19 and a high of $263.05 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RMD stock was last observed hovering at around $223.00 in the last trading session, with the day’s loss setting it -9.65%.
Currently trading at $213.35, the stock is -4.28% and -8.04% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.51 million and changing -4.33% at the moment leaves the stock -7.55% off its SMA200. RMD registered 15.72% gain for a year compared to 6-month loss of -10.64%. The firm has a 50-day simple moving average (SMA 50) of $231.9938 and a 200-day simple moving average (SMA200) of $230.76985.
The stock witnessed a -4.68% gain in the last 1 month and extending the period to 3 months gives it a -6.71%, and is -4.16% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.64% over the week and 2.81% over the month.
Resmed Inc (RMD) has around 9980 employees, a market worth around $31.33B and $4.93B in sales. Current P/E ratio is 25.20 and Fwd P/E is 20.42. Profit margin for the company is 25.35%. Distance from 52-week low is 23.90% and -18.89% from its 52-week high. The company has generated returns on investments over the last 12 months (20.62%).
with sales reaching $1.29B over the same period.The EPS is expected to grow by 22.89% this year, but quarterly earnings will post 9.16% year-over-year. Quarterly sales are estimated to grow 7.37% in year-over-year returns.
1281.0 institutions hold shares in Resmed Inc (RMD), with institutional investors hold 63.29% of the company’s shares. The shares outstanding are 146.86M, and float is at 145.81M with Short Float at 5.99%. Institutions hold 62.86% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 17.9 million shares valued at $3.43 billion. The investor’s holdings represent 12.1805 of the RMD Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.69 million shares valued at $2.24 billion to account for 7.9583 of the shares outstanding. The other top investors are STATE STREET CORP which holds 6.14 million shares representing 4.1825 and valued at over $1.18 billion, while BANK OF NEW YORK MELLON CORP holds 3.9281 of the shares totaling 5.77 million with a market value of $1.11 billion.
Resmed Inc (RMD) Insider Activity
The most recent transaction is an insider sale by Rider Michael J, the company’s Global General Counsel. SEC filings show that Rider Michael J sold 64 shares of the company’s common stock on Apr 01 ’25 at a price of $222.86 per share for a total of $14263.0. Following the sale, the insider now owns 8846.0 shares.
Still, SEC filings show that on Apr 01 ’25, Rider Michael J (Officer) Proposed Sale 64 shares at an average price of $222.86 for $14263.0. The insider now directly holds shares of Resmed Inc (RMD).
